PortfoliosLab logo

Avenue Therapeutics, Inc. (ATXI)

Equity · Currency in USD · Last updated May 21, 2022

Company Info

Trading Data

  • Previous Close$0.29
  • Year Range$0.22 - $5.07
  • EMA (50)$0.45
  • EMA (200)$1.25
  • Average Volume$465.30K
  • Market Capitalization$6.32M

ATXIShare Price Chart


Chart placeholderClick Calculate to get results

ATXIPerformance

The chart shows the growth of $10,000 invested in Avenue Therapeutics, Inc. on Jun 27, 2017 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $485 for a total return of roughly -95.15%. All prices are adjusted for splits and dividends.


ATXI (Avenue Therapeutics, Inc.)
Benchmark (^GSPC)

ATXIReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-38.74%-12.57%
YTD-67.95%-18.14%
6M-76.90%-17.07%
1Y-93.53%-5.21%
5Y-46.07%10.06%
10Y-46.07%10.06%

ATXIMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

ATXISharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Avenue Therapeutics, Inc. Sharpe ratio is -0.62. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


ATXI (Avenue Therapeutics, Inc.)
Benchmark (^GSPC)

ATXIDividend History


Avenue Therapeutics, Inc. doesn't pay dividends

ATXIDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


ATXI (Avenue Therapeutics, Inc.)
Benchmark (^GSPC)

ATXIWorst Drawdowns

The table below shows the maximum drawdowns of the Avenue Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Avenue Therapeutics, Inc. is 98.22%, recorded on Feb 23, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.22%Sep 15, 2020364Feb 23, 2022
-74.55%Jun 28, 2017325Oct 10, 2018304Dec 26, 2019629
-43.11%Feb 11, 202026Mar 18, 202050May 29, 202076
-18.31%Jun 1, 202030Jul 13, 202026Aug 18, 202056
-11.46%Jan 2, 202010Jan 15, 20208Jan 28, 202018
-7.42%Aug 21, 20205Aug 27, 202011Sep 14, 202016
-4.24%Jan 29, 20202Jan 30, 20202Feb 3, 20204
-2.29%Feb 5, 20201Feb 5, 20201Feb 6, 20202

ATXIVolatility Chart

Current Avenue Therapeutics, Inc. volatility is 62.00%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


ATXI (Avenue Therapeutics, Inc.)
Benchmark (^GSPC)

Portfolios with Avenue Therapeutics, Inc.


Loading data...

More Tools for Avenue Therapeutics, Inc.